NCT03384108 In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells
| NCT ID | NCT03384108 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2017-09-01 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2017-09-01 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot study will first establish the feasibility of an in vivo methodology of assessing the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells from healthy subjects while comparing it to an ex vivo approach
Eligibility Criteria
Inclusion Criteria: * Ages 18-60 * Able to provide written consent Exclusion Criteria: * Renal Failure * Pregnancy * Active steroid use * Active liver Disease * Anemia (Hemoglobin \< 12.5 g/dL in men and \< 11.5 g/dL in women) * H/O alcohol use (average \> 2 drinks per day) * BMI \> 30
Contact & Investigator
Wilson Gonsalves, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT03384108 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03384108 currently recruiting?
Yes, NCT03384108 is actively recruiting participants. Contact the research team at gonsalves.wilson@mayo.edu for enrollment information.
Where is the NCT03384108 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT03384108 clinical trial?
NCT03384108 is sponsored by Mayo Clinic. The principal investigator is Wilson Gonsalves, MD at Mayo Clinic. The trial plans to enroll 20 participants.